Exact Sciences
EXAS
#1166
Rank
C$28.47 B
Marketcap
C$149.16
Share price
0.00%
Change (1 day)
98.67%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

EPS for Exact Sciences (EXAS)

EPS in 2025 (TTM): C-$7.63

According to Exact Sciences's latest financial reports the company's current EPS (TTM) is C-$7.56. In 2024 the company made an earnings per share (EPS) of C-$7.92.

EPS history for Exact Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$7.63-3.64%
2024C-$7.92
2022C-$5.032.31%
2021C-$4.92-38.54%
2020C-$8.00692.96%
2019C-$1.01-50.69%
2018C-$2.0544%
2017C-$1.42-39.39%
2016C-$2.35-2.94%
2015C-$2.4237.1%
2014C-$1.7679.71%
2013C-$0.98-21.59%
2012C-$1.25

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
C$2.71-135.77%๐Ÿ‡ซ๐Ÿ‡ท France
Veracyte
VCYT
C$2.05-127.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
C$0.48-106.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
C-$1.69-77.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
C-$72.37 856.77%๐Ÿ‡บ๐Ÿ‡ธ USA